chevron_leftBack
As of 20 June 2026, Gujarat Terce Laboratories Ltd. has a market cap of $3.14M USD, ranking #46075 globally and #4249 in India.
It ranks #4089 in the Healthcare sector, and #1308 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$3.14MUSD
296.07M INR
Enterprise Value
$3.1MUSD
292.58M INR
Revenue (TTM)
$5.13MUSD
483.98M INR
EBITDA (TTM)
$430.58KUSD
40.66M INR
Net Income (TTM)
-$135.7KUSD
-12.81M INR
EBITDA Margin
8.4%
Profit Margin
-2.6%
PS Ratio
0.6
EV/EBITDA
7.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Aalap Prajapati
open_in_new
Employees
244
Founded
1985
Website
gujaratterce.in
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 2.7% | -5.1% | 12% | -20% | -25% | -41% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
524314
(GUJTERC)
Gujarat Terce Laboratories Ltd
ISIN: INE499G01013
Shares Out.:
Shares Outstanding:
7.791M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
38.00 INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Gujarat Terce Laboratories Ltd.
Gujarat Terce Laboratories Limited develops, manufactures, markets, and distributes medicines and healthcare products in India and internationally. The company offers generic pharmaceutical for therapeutic areas, such as antibiotics, respiratory, nutraceuticals, gastrology, gynecology, pain therapy, and ayurvedic. It provides tablets, capsules, oral liquids, ointments, and injections under the Acolate, Tynol, Resplash, Ferlit, Z-Oxi, Vitfol, Thyter, Aziter, Codimol, Cefter, and Terflora brands. Gujarat Terce Laboratories Limited was incorporated in 1985 and is based in Ahmedabad, India.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NSE: SUNPHARMA
|
$45.22B
1M%
4.27T INR
|
39.1
|
|
NSE: DIVISLAB
|
$18.38B
586K%
1.73T INR
|
70.0
|
|
NSE: TORNTPHARM
|
$15.17B
483K%
1.43T INR
|
63.0
|
|
NSE: DRREDDY
|
$11.73B
374K%
1.11T INR
|
19.6
|
|
NSE: MANKIND
|
$9.87B
315K%
931.67B INR
|
52.2
|
|
NSE: ZYDUSLIFE
|
$9.71B
309K%
916.53B INR
|
18.6
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
24M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
17M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
11M%
|
97.4
|
|
SIX: RO
|
$318.3B
10M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$284.64B
9M%
215.59B GBP
|
27.6
|
|
NYSE: MRK
|
$274.03B
9M%
|
15.1
|
chevron_leftBack